PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors
Public ClinicalTrials.gov record NCT00819780. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Multicenter, Phase 2 Study to Compare the Efficacy of Panitumumab in Combination With mFOLFOX6 to the Efficacy of Bevacizumab in Combination With mFOLFOX6 in Patients With Previously Untreated, KRAS Wild-Type, Unresectable, Metastatic Colorectal Cancer
Study identification
- NCT ID
- NCT00819780
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Amgen
- Industry
- Enrollment
- 285 participants
Conditions and interventions
Interventions
- Panitumumab Drug
- Bevacizumab Drug
- mFOLFOX6 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 23, 2009
- Primary completion
- May 29, 2012
- Completion
- Jul 6, 2016
- Last update posted
- Dec 5, 2022
2009 – 2016
United States locations
- U.S. sites
- 63
- U.S. states
- 26
- U.S. cities
- 62
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | 35205 | — |
| Research Site | Huntsville | Alabama | 35805 | — |
| Research Site | Berkeley | California | 94704 | — |
| Research Site | Beverly Hills | California | 90211 | — |
| Research Site | Burbank | California | 91505 | — |
| Research Site | Fountain Valley | California | 92708 | — |
| Research Site | La Verne | California | 91750 | — |
| Research Site | Orange | California | 92868 | — |
| Research Site | Riverside | California | 92501 | — |
| Research Site | Roseville | California | 95661 | — |
| Research Site | Denver | Colorado | 80218 | — |
| Research Site | Stamford | Connecticut | 06902 | — |
| Research Site | Waterbury | Connecticut | 06708 | — |
| Research Site | Boynton Beach | Florida | 33435 | — |
| Research Site | Coral Springs | Florida | 33065 | — |
| Research Site | Daytona Beach | Florida | 32114 | — |
| Research Site | Hollywood | Florida | 33021 | — |
| Research Site | Lake Worth | Florida | 33467 | — |
| Research Site | Alpharetta | Georgia | 30005 | — |
| Research Site | Augusta | Georgia | 30901 | — |
| Research Site | Savannah | Georgia | 31405 | — |
| Research Site | Post Falls | Idaho | 83854 | — |
| Research Site | Gurnee | Illinois | 60031 | — |
| Research Site | Peoria | Illinois | 61615 | — |
| Research Site | Indianapolis | Indiana | 46237 | — |
| Research Site | Overland Park | Kansas | 66210 | — |
| Research Site | Wichita | Kansas | 67214 | — |
| Research Site | Danville | Kentucky | 40422 | — |
| Research Site | Hazard | Kentucky | 41701 | — |
| Research Site | Paducah | Kentucky | 42003 | — |
| Research Site | Baltimore | Maryland | 21204 | — |
| Research Site | Bethesda | Maryland | 20817 | — |
| Research Site | Boston | Massachusetts | 02111 | — |
| Research Site | Kalamazoo | Michigan | 49048 | — |
| Research Site | Lambertville | Michigan | 48144 | — |
| Research Site | Lansing | Michigan | 48912 | — |
| Research Site | Mountain Lakes | New Jersey | 07046 | — |
| Research Site | Sparta | New Jersey | 07871 | — |
| Research Site | Albuquerque | New Mexico | 87131 | — |
| Research Site | Buffalo | New York | 14215 | — |
| Research Site | East Setauket | New York | 11733 | — |
| Research Site | Staten Island | New York | 10301 | — |
| Research Site | Huntersville | North Carolina | 28078 | — |
| Research Site | Raleigh | North Carolina | 27607 | — |
| Research Site | Akron | Ohio | 44304 | — |
| Research Site | Columbus | Ohio | 43228 | — |
| Research Site | Hershey | Pennsylvania | 17033 | — |
| Research Site | Philadelphia | Pennsylvania | 19106 | — |
| Research Site | Greenville | South Carolina | 29605 | — |
| Research Site | Mt. Pleasant | South Carolina | 29464 | — |
| Research Site | Memphis | Tennessee | 38120 | — |
| Research Site | Austin | Texas | 78759 | — |
| Research Site | Corpus Christi | Texas | 78463 | — |
| Research Site | Dallas | Texas | 75231 | — |
| Research Site | Round Rock | Texas | 78665 | — |
| Research Site | Temple | Texas | 76508 | — |
| Research Site | Tyler | Texas | 75702 | — |
| Research Site | White River Junction | Vermont | 05009 | — |
| Research Site | Chesapeake | Virginia | 23320 | — |
| Research Site | Newport News | Virginia | 23601 | — |
| Research Site | Newport News | Virginia | 23606 | — |
| Research Site | Spokane | Washington | 99218 | — |
| Research Site | Vancouver | Washington | 98684 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 32 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00819780, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 5, 2022 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00819780 live on ClinicalTrials.gov.